Lonza Argentina SA.’s Acquisition of Arch Química Argentina’s Assets

Marval, O’Farrell & Mairal acted as legal counsel on the deal

Lonza Argentina SA. executed the acquisition of Arch Química Argentina’s assets.

Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and specialty ingredients markets worldwide. The company, led by Richard Ridinger operates through two segments, Pharma&Biotech and Specialty Ingredients.

Arch Quimica Argentina S.R.L. operates as a subsidiary of Arch Chemicals Inc. The company provides chemistry-based and related solutions to destroy or to selectively inhibit the growth of harmful microorganisms.

Marval acted as legal counsel on the deal with a team including Pablo Artagaveytia (Picture), Hugo Jong Uk Woo and Verónica Raffaeli.

Involved fees earner: Verónica Vivian Raffaeli – Marval, O’Farrell & Mairal; Pablo Artagaveytia – Marval, O’Farrell & Mairal; Hugo Jong Uk Woo – Marval, O’Farrell & Mairal;

Law Firms: Marval, O’Farrell & Mairal;

Clients: Arch Chemicals, Inc.; Lonza Group AG.;


Author: Ambrogio Visconti.